The Effect of A Dental Application to Promote Self-Administered Plaque Control: A RCT

February 10, 2022 updated by: National University Hospital, Singapore

The Effect of An Artificial Intelligence ("AI") Mobile Dental Application ("Dental Monitoring") in the Promotion of Self-Administered Plaque Control: A Randomized Controlled Trial

Randomized Controlled Trial: to investigate the feasibility of the usage of a mobile dental application in the self-administration of plaque control in a two (2) parallel arm study with 52 subjects (n = 52). The study will take place over 2 visits (within 35 days): Visit 1 and 2.

Prospective Open Cohort Study: Patients referred to the Periodontology Department will be invited to participate in the study during the Oral Hygiene Phase. Routine clinical indices will be recorded at Visit 1 and Visit 2 before active non-surgical periodontal treatment commences.

Study Overview

Detailed Description

Visit 1 (Week 0, Day 0): Start of Study

  • Subjects: The periodontal patients who have a dental appointment scheduled in the National University Centre for Oral Health, Singapore and fulfil inclusion/exclusion criteria will be recruited into the study by the delegated study team members. After written informed consent has been obtained and all the standard dental practices such as collecting the Routine Clinical Periodontal Parameters for evaluation and providing Oral Hygiene Instruction are done by the blinded study team member(s) termed as the Examiner. After which, the Participants will be randomized into 2 groups by delegated study team members.
  • There will be two groups:

    • Test (n = 26): Dental Monitoring ("DM") Kit + 2-month DM subscription
    • Control (n = 26): No DM Kit
  • The Examiner will be either the Co-investigator or an oral hygiene therapist engaged to be on the delegated study team. The same single blinded Examiner will examine all the participants of the study at both Visits 1 and 2.
  • Based on the design of the study, there will be no deviation from the standard periodontal treatment protocol and intervals between treatment for this group of patients in the public healthcare setting with the exception for the test groups whereby the usage of an additional DM application which will be evaluated in this study.
  • The Test group will receive DM as an additional monitoring aid. The delegated study team members will guide the Test group to download the DM application onto their mobile device, provide them with a DM Kit including full instructions (verbal and instruction pamphlet).
  • In addition, the Test group will be taught by the delegated study team members:

    1. How to pair up a DM Scanbox with your smartphone https://youtu.be/y-q9Z8JMbzo
    2. How to perform DM Scans with ScanBox https://youtu.be/YT859VMGL18
  • The Test group will be required to take intra-oral videos (which will be translated into photographs) using the DM application weekly and it will be monitored by the delegated team members:

    • Day 0 (To be taken at the clinic)
    • Day 7 (To be taken in the evening after brushing teeth)
    • Day 14 (To be taken in the evening after brushing teeth)
    • Day 21(To be taken in the evening after brushing teeth)
    • Day 28 (To be taken before study Visit 2) *There is a window period of +1 day for the intra-oral videos.
  • The Control group will monitor their own oral hygiene without any additional aids.
  • All patients will be given a soft-bristled toothbrush, fluoridated toothpaste and inter-dental aids by the delegated study team members. They will be instructed not to use any forms of mouth rinse.

Visit 2 (Week 4, Day 28 to Day 35): End of Study

  • This visit will be between Day 28 and 35.
  • The Test group will be given a short questionnaire by delegated study team members to evaluate their perspective on the "ease of use" and "satisfaction" using DM.
  • The same Routine Clinical Periodontal Parameters clinical parameters will be measured again by the same blinded Examiner in Visit 1 and the clinical parameters evaluated.
  • At the end of Visit 2, the subject will need to return the DM Kit during this visit. There is no more post follow up for this study and patient will continue with their next scheduled dental appointment by their primary care team.
  • The delegated study team will collect the data from the Routine Clinical Periodontal Parameters (Full Mouth Periodontal Probing Depth, Bleeding on Probing, Recession and Plaque Index) that have been recorded at Visit 1 and Visit 2 for the following:

    • Primary Outcome: Difference in Full Mouth Plaque Score (%)
    • Secondary Outcomes: Participants' experience/feedback in the Test group on the use of the Dental Monitoring application.
  • The delegated study team will analyze the photographs taken by the DM application and the data collected via the questionnaire.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119074
        • National University Hospital, Singapore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Aged between 21 and 65 years old
  2. Dentate patients
  3. English speaking and literacy for verbal instructions including the usage of the DM application
  4. Have access or own a smartphone with wifi and/or cellular connectivity
  5. Ability to provide informed consent to participate in the study and willing to download the DM application onto their smartphone
  6. Able to link and register their email account to receive notifications from DM application during the study

Exclusion Criteria:

  1. Patients below 21 years old
  2. Patients who is in dental pain
  3. Patients with dementia
  4. Patients who has compromised manual dexterity
  5. Patients who had received Scaling and Polishing less than one month prior to examination and treatment
  6. Pregnant or lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test: With Dental Monitoring

Dental Monitoring ("DM") Kit + 2-month DM subscription

Required to take intra-oral videos (which will be translated into photographs) using the DM application weekly and it will be monitored by the delegated team members:

  • Day 0 (To be taken at the clinic)
  • Day 7 (To be taken in the evening after brushing teeth)
  • Day 14 (To be taken in the evening after brushing teeth)
  • Day 21(To be taken in the evening after brushing teeth)
  • Day 28 (To be taken before study Visit 2)

There is a window period of +1 day for the intra-oral videos.

o The Test group will be required to take intra-oral videos (which will be translated into photographs) using the DM application weekly and it will be monitored by the delegated team members:

  • Day 0 (To be taken at the clinic)
  • Day 7 (To be taken in the evening after brushing teeth)
  • Day 14 (To be taken in the evening after brushing teeth)
  • Day 21(To be taken in the evening after brushing teeth)
  • Day 28 (To be taken before study Visit 2) There is a window period of +1 day for the intra-oral videos.
No Intervention: Control: Without Dental Monitoring
No DM Kit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Full Mouth Plaque Score (%)
Time Frame: Between Visit 1 (Day 0) and Visit 2 (between Day 28 and 35)
Difference in Full Mouth Plaque Score using the disclosing two tone liquid by Curaprox
Between Visit 1 (Day 0) and Visit 2 (between Day 28 and 35)
Full Mouth Bleeding Score (%)
Time Frame: Between Visit 1 (Day 0) and Visit 2 (between Day 28 and 35)
Difference in Full Mouth Bleeding Score using a UNC periodontal probe, 6 surfaces per tooth (mesio-buccal, mid buccal, disco-buccal, mesio-lingual, mid-lingual and ditto-lingual) will be measured
Between Visit 1 (Day 0) and Visit 2 (between Day 28 and 35)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction and Ease of Usage of the Dental Monitoring Application/Kit
Time Frame: At the end of Visit 2 (between Day 28 and 35)
Participants' experience/feedback in the Test group on the use of the Dental Monitoring application.
At the end of Visit 2 (between Day 28 and 35)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jia Hui Fu, Dr, National University Centre for Oral Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2021

Primary Completion (Actual)

January 14, 2022

Study Completion (Actual)

January 14, 2022

Study Registration Dates

First Submitted

September 2, 2021

First Submitted That Met QC Criteria

October 6, 2021

First Posted (Actual)

October 11, 2021

Study Record Updates

Last Update Posted (Actual)

February 15, 2022

Last Update Submitted That Met QC Criteria

February 10, 2022

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Mobile Dental Application, Dental Monitoring ("DM")

Subscribe